Skip to content

Bronchial Thermoplasty Study: an observational study examining airway remodelling and repair in patients with severe persistent asthma treated with bronchial thermoplasty

An observational study examining airway remodelling and repair in patients with severe persistent asthma treated with bronchial thermoplasty: an imaging and immunopathological study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN94263922
Enrollment
20
Registered
2013-07-16
Start date
2013-03-04
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Respiratory

Interventions

3He, 129Xe and 1H MRI imaging, Functional lung MRI with hyperpolarised (HP) gas MRI (Helium-3 and Xenon-129 MRI) and 1H perfusion MRI before and after thermoplasty to explore the relation between chan

Sponsors

University of Leicester (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Written informed consent must be obtained before any assessment is performed 2. Males and females of any race who are over the age of 18 years at the time informed the consent is obtained 3. Physician diagnosis of asthma, as per Global Initiative for Asthma (GINA) guidelines and currently prescribed inhaled corticosteroid (ICS) or inhaled corticosteroid-long-acting beta agonist (ICS-LABA) therapy GINA step 3 to step 5 asthma therapies 4. Patients assigned by the clinical team to receive bronchial thermoplasty as part of their asthma treatment plan

Exclusion criteria

Exclusion criteria: 1. Patients who are considered unsuitable for inclusion by the assessing physician due to serious co-morbidities such as cancer, emphysema or significant bronchiectasis 2. Recent (within 4 weeks of visit 1) or current lower respiratory tract infection 3. A positive hepatitis B surface antigen or hepatitis C virus antibody, as determined by medical history and/or subject?s verbal report 4. A positive human immunodeficiency virus test or is taking anti-retroviral medications, as determined by medical history and/or subject?s verbal report Additional exclusion criteria for patients who have agreed to take part in the MR Imaging part of the study 4.1. Patients with a contra-indication to MRI scanning: i.e. patients who are non MRI compatible (ferro-magnetic metallic implants, pacemakers) as per the MRI questionnaire 4.2. Patients with potential adverse reactions to Gd-DTPA intravascular MRI contrast agent

Design outcomes

Primary

MeasureTime frame
Changes in immunopathological features following thermoplasty; Timepoint(s): Before thermoplasty, 3 weeks post thermoplasty and 6 weeks post thermoplasty

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026